TP53 and osteosarcoma: Chen et al have shown that GRK5 phosphorylates p53 at Thr-55 and promotes its degradation, thus inhibiting p53-mediated apoptosis both in vitro (Fig. 3), in cultured human osteosarcoma cells, and in vivo [73].